Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Sergio Traversa

CEO at Relmada Therapeutics, Inc. (RLMD)

Purchase track record

Strong record. Based on 2 purchases with a full 90 days of price history.

93
Avg. 90-day return+38.6%
vs. S&P 500+37.8%
Beat the market100%
Paper profit on buys+$154K
Total bought / sold$1.5M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Sep 11SEC RLMDRelmada Therapeutics, Inc. Buy 100,0001,400,000 held (+8%) $4.18 $418K -18.9%
Sep 11SEC RLMDRelmada Therapeutics, Inc. Buy 100,0001,500,000 held (+7%) $4.10 $410K -17.3%
Dec 16SEC RLMDRelmada Therapeutics, Inc. Buy 27,5001,300,000 held (+2%) $4.12 $113K -17.7%
Nov 6SEC RLMDRelmada Therapeutics, Inc. Buy 272,5001,272,500 held (+27%) $2.20 $600K +54.1%
  • Buy

    CEO Sergio Traversa bought $600K of RLMD at $2.20 — first open-market purchase in our records; raises the stake by 27%.